Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor β-induced repression of c-myc

Cancer Research

Volumn 63, Issue 4, 2003, Pages 801-806

  Sasaki, Toru ^a   Suzuki, Hiroyuki ^a,b   Yagi, Ken ^a   Furuhashi, Masao ^a   Yao, Ryoji ^a   Susa, Shinji ^a   Noda, Tetsuo ^a   Arai, Yoichi ^d   Miyazono, Kohei ^a,b   Kato, Mitsuyasu ^a,c  

^a CANCER INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LYMPHOID ENHANCER FACTOR 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL LINE; COLON CANCER; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOWN REGULATION; GENE REPRESSION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; BETA CATENIN; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; GENES, MYC; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0037442685     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. de Caestecker, M. P., Piek, E., and Roberts, A. B. Role of transforming growth factor-β signaling in cancer. J. Natl. Cancer Inst. (Bethesda), 92: 1388-1402, 2000.
2. Massagué, J., Blain, S. W., and Lo, R. S. TGFβ signaling in growth control, cancer, and heritable disorders. Cell, 103: 295-309, 2000.
3. Derynck, R., Akhurst, R. J., and Balmain, A. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet., 29: 117-129, 2001.
4. Xie, W., Mertens, J. C., Reiss, D. J., Rimm, D. L., Camp, R. L., Haffty, B. G., and Reiss, M. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. Cancer Res., 62: 497-505, 2002.
5. Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Munger, K., Howley, P. M., and Moses, H. L. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell, 61: 777-785, 1990.
6. Datto, M. B., Hu, P. P., Kowalik, T. F., Yingling, J., and Wang, X. F. The viral oncoprotein E1A blocks transforming growth factor β-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol. Cell. Biol., 17: 2030-2037, 1997.
7. Kurokawa, M., Mitani, K., Irie, K., Matsuyama, T., Takahashi, T., Chiba, S., Yazaki, Y., Matsumoto, K., and Hirai, H. The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3. Nature (Lond.). 394: 92-96, 1998.
8. Mori, N., Morishita, M., Tsukazaki, T., Giam, C. Z., Kumatori, A., Tanaka, Y., and Yamamoto, N. Human T-cell leukemia virus type 1 oncoprotein Tax represses Smad-dependent transforming growth factor β signaling through interaction with CREB-binding protein/p300. Blood. 97: 2137-2144, 1999.
9. Sun, Y., Liu, X., Eaton, E. N., Lane, W. S., Lodish, H. F., and Weinberg, R. A. Interaction of the Ski oncoprotein with Smad3 regulates TGF-β signaling. Mol. Cell, 4: 499-509, 1999.
10. Kretzschmar, M., Doody, J., Timokhina, I., and Massagué, J. A mechanism of repression of TGF β/Smad signaling by oncogenic Ras. Genes Dev., 13: 804-816, 1999.
11. Lo, R. S., Wotton, D., and Massagué, J. Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. EMBO J., 20: 128-136, 2001.
12. Mulder, K. M., Zhong, Q., Choi, H. G., Humphrey, L. E., and Brattain, M. G. Inhibitory effects of transforming growth factor β1 on mitogenic response, transforming growth factor α, and c-myc in quiescent, well-differentiated colon carcinoma cells. Cancer Res., 50: 7581-7586, 1990.
13. Usa, T., Tsukazaki, T., Namba, H., Ohtsuru, A., Kimura, H., Villadolid, M. C., Nagataki, S., and Yamashita, S. Correlation between suppression of c-myc and antiproliferative effect of transforming growth factor-β1 in thyroid carcinoma cell growth. Endocrinology, 135: 1378-1384, 1994.
14. Paterson, I. C., Patel, V., Sandy, J. R., Prime, S. S., and Yeudall, W. A. Effects of transforming growth factor-β1 on growth-regulatory genes in tumour-derived human oral keratinocytes. Br. J. Cancer, 72: 922-927, 1995.
15. Chen, C. R., Kang, Y., and Massagué, J. Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor β growth arrest program. Proc. Natl. Acad. Sci. USA. 98: 992-999, 2001.
16. Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., and Kato, M. c-myc is a downstream target of the Smad pathway. J. Biol. Chem., 277: 854-861, 2002.
17. Bienz, M., and Clevers, H. Linking colorectal cancer to Wnt signaling. Cell, 103: 311-320, 2000.
18. Polakis, P. Wnt signaling and cancer. Genes Dev., 14: 1837-1851, 2000.
19. de La Coste, A., Romagnolo, B., Billuart, P., Renard, C. A., Buendia, M. A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., and Perret, C. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA, 95: 8847-8851, 1998.
20. Michaelson, J. S., and Leder, P. β-Catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene. 20: 5093-5099, 2001.
21. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science (Wash. DC), 281: 1509-1512, 1998.
22. Labbe, E., Letamendia, A., and Attisano, L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and wnt pathways. Proc. Natl. Acad. Sci. USA, 97: 8358-8363, 2000.
23. Nishita, M., Hashimoto, M. K., Ogata, S., Laurent, M. N., Ueno, N., Shibuya, H., and Cho, K. W. Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer. Nature (Lond.). 403: 781-785, 2000.
24. Hovanes, K., Li, T. W., Munguia, J. E., Truong, T., Milovanovic, T., Lawrence Marsh, J., Holcombe, R. F., and Waterman, M. L. β-Catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat. Genet., 28: 53-57, 2001.
25. Murakami, T., Toda, S., Fujimoto, M., Ohtsuki, M., Byers, H. R., Etoh, T., and Nakagawa, H. Constitutive activation of Wnt/β-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Biochem. Biophys. Res. Commun. 288: 8-15, 2001.
26. Goto, D., Yagi, K., Inoue, H., Iwamoto, I., Kawabata, M., Miyazono, K., and Kato, M. A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-β signals. FEBS Lett., 430: 201-204, 1998.
27. Yagi, K., Goto, D., Hamamoto, T., Takenoshita, S., Kato, M., and Miyazono, K. Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J. Biol. Chem., 274: 703-709, 1999.
28. Grandori, C., Cowley, S. M., James, L. P., and Eisenman, R. N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol., 16: 653-699, 2000.
29. Claassen, G. F., and Hann, S. R. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrest. Proc. Natl. Acad. Sci. USA, 97: 9498-9503, 2000.
30. Henriksson, M., and Luscher, B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res., 68: 109-182, 1996.
31. Filali, M., Cheng, N., Abbott, D., Leontiev, V., and Engelhardt, J. F. Wnt-3A/β-catenin signaling induces transcription from the LEF-1 promoter. J. Biol. Chem., 277: 33398-33410, 2002.
32. Tutter, A. V., Fryer, C. J., and Jones, K. A. Chromatin-specific regulation of LEF-1-β-catenin transcription activation and inhibition in vitro. Genes Dev., 15: 3342-3354, 2001.